Loading quotes...
Forecast
The analysts' average price target is €40.04 (+7.35%). The median is €40.49 (+8.55%).
| Buy |
6 |
| Hold |
1 |
| Sell |
0 |
News Go to news feed
Pennant Group beats Q2 estimates and raises full-year outlook
For Q2 2026 Pennant Group reported adjusted earnings of $0.36 per share and revenue of $298.0 million, both above consensus estimates, with revenue up 35.8% and adjusted EBITDA up 48.2%. Management raised its full-year guidance, citing faster integration of acquisitions and organic growth in home care, hospice services and senior living. The stock was little changed, while analysts see valuation risks and investors should monitor the sustainability of growth as integration continues. » More on de.investing.com
Pennant Group reaches 52-week high at $42.58
Pennant Group shares climbed to a new yearly high of $42.58, giving the company a market capitalization of $1.48 billion. The stock rose 84.73% year‑over‑year, supported by revenue growth of 36.76% over the last twelve months. Analysts raised earnings estimates, but the P/E ratio stands at 49.12, suggesting possible overvaluation. Pennant reported strong Q1 results (EPS $0.32; revenue $285.36 million) and acquired Copper Canyon Memory Care (40 units) to expand in Arizona, bringing its presence to 17 states. » More on de.investing.com
Pennant Group reaches 52-week high at $42.55
Pennant Group's stock climbed to a 52-week high of $42.55 and is up about 80.64% year over year. The company has a market capitalization of $1.46 billion, with revenue growth of 37% over the past twelve months; the P/E ratio is 48.33 according to InvestingPro. In Q1 2026 Pennant beat expectations with EPS of $0.32 and revenue of $285.36 million and announced the acquisition of Copper Canyon Memory Care (40 units) in Tucson. » More on de.investing.com
Financials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 261.1m | 40.20% |
| Gross profit | 36.73m | 42.88% |
| Net profit | 7.96m | 32.38% |
| EBITDA | 16.91m | 42.32% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.32bn |
Number of shares | 34.93m |
52-week high/low | €38.46 - €20.03 |
| Dividends | No |
Beta | 1.25 |
P/E ratio | 44.55 |
PEG ratio | 2.78 |
P/B ratio | 4.06 |
P/S ratio | 1.33 |
Company profile
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
| Name | PENNANT GROUP DL -,001 |
| CEO | Brent J. Guerisoli |
| Headquarters | Eagle,
id USA |
| Website | |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| IPO | 01/10/2019 |
| Employees | 9,700 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NASDAQ | PNTG |
Frankfurt | 1ZU.F |
Düsseldorf | 1ZU.DU |
München | 1ZU.MU |